MedTrace Logo

Retrospective Experience Of CIED Implantation

NCT04351269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 597

Last updated 2023-07-21

Study results available
· View outcomes & findings →

Summary

The objective of this study is to retrospectively gather information on patients who underwent a CIED procedure with either a CanGaroo Envelope, TYRX Envelope, or no envelope.

Conditions

Interventions

DEVICE

CanGaroo Envelope

CanGaroo Envelope with Cardiac Implantable Electronic Device (CIED) implantation

DEVICE

TYRX Envelope

TYRX Envelope with Cardiac Implantable Electronic Device (CIED) implantation

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Principal Investigators

  • Jerome Riebman, MD · Aziyo Biologicgs, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2021-06-30
Completion
2021-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04351269 on ClinicalTrials.gov